News BEL-20

Index

BEL20

BE0389555039

Real-time Euronext Bruxelles 03:09:15 2024-04-18 am EDT			5-day change	1st Jan Change
3,793 ^PTS	-0.05%		-0.90%	+2.42%

Apr. 15	Solvay: Deutsche Bank's assessment that the company is well valued causes the share price to fall.	CF
Apr. 04	UCB: new indication in sight for Bimzelx in the USA	CF

All news about BEL-20

Solvay: Deutsche Bank's assessment that the company is well valued causes the share price to fall.	Apr. 15	CF
UCB: new indication in sight for Bimzelx in the USA	Apr. 04	CF
Solvay: share price advances, DME Capital strengthens further	Mar. 20	CF
Euronav to exit Belgium's blue-chip index two days after joining	Mar. 19	RE
Aperam: forthcoming delisting from BEL20	Mar. 07	CF
KBC: unsurprising results, but attractive forecasts	Feb. 08	CF
AB InBev: share price advances, Jefferies optimistic	Jan. 10	CF
Ageas: Amundi falls below the 3% capital threshold	Dec. 29	CF
Mithra : Goldman Sachs reduces its stake to below 3%.	Dec. 27	CF
PCE inflation doesn’t disappoint	Dec. 22
KBC: ECB raises capital requirement	Dec. 13	CF
Syensqo to join the BEL 20 on December 18	Dec. 12	CF
Syensqo: share price rises sharply on its stock market debut	Dec. 11	CF
Gimv: arrival of a new reference shareholder	Dec. 01	CF
Ageas: supported by Berenberg's buy recommendation	Nov. 24	CF

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

D'Ieteren : Repurchase and disposal of own shares DIE	Apr. 17	PU
Solvay releases 2023 annual integrated report SOLB	Apr. 17	GL
AB INBEV : Bernstein maintains a Buy rating ABI	Apr. 17	ZD
Transcript : Proximus PLC - Shareholder/Analyst Call PROX	Apr. 17
Proximus : Art Collection will place a selection of artworks on the market and use the proceeds for new acquisitions PROX	Apr. 17	PU
UCB : FINTEPLA▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) UCB	Apr. 17	PU
Argenx : argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ARGX	Apr. 16	PU
Syensqo releases inaugural 2023 annual integrated report SYENS	Apr. 16	GL
KBC Group: Update regarding the KBC Group share buyback programme KBC	Apr. 16	GL
Argenx Data Highlight Evidence that VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients with Debilitating Autoimmune Disease ARGX	Apr. 16	GL
Argenx SE Announces Data from its Phase 3 ADHERE Trial Evaluating VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy ARGX	Apr. 16	CI
Groupe Bruxelles Lambert : GBL - Transactions sur actions propres 15-04-2024 GBLB	Apr. 15	PU
Groupe Bruxelles Lambert : GBL - Transactions on GBL shares 15-04-2024 GBLB	Apr. 15	PU
Groupe Bruxelles Lambert : GBL - Transacties op GBL-aandelen 15-04-2024 GBLB	Apr. 15	PU
Solvay publishes 2023 quarterly information following restatement and new segmentation reporting SOLB	Apr. 15	GL

No results for this search

News in other languages on BEL-20

Brussel start handelsdag naar verwachting licht hoger	02:08am
Bodenbildung - Berichtssaison setzt Akzente	Apr. 17
Bel20 kan geen richting kiezen	Apr. 17
Video: oplopende rente en hoge inflatie geen probleem voor aandelen	Apr. 17
Argenx weer in het rood	Apr. 17
Brusselse beurs in de plus	Apr. 17
Brusselse beurs opent afwachtend	Apr. 17
Licht lagere opening Bel20 voorzien	Apr. 17
"Steigende Zinsen sind Gift für die Börse"	Apr. 16
Bel20 de dieperik in	Apr. 16
Bel20 stevig in het rood	Apr. 16
Brusselse beurs stevig onder druk	Apr. 16
Brusselse beurs opent fors lager	Apr. 16
Brussel wacht rode opening	Apr. 16
Etwas fester - Iranischer Angriff lässt Anleger kalt	Apr. 15

Headlines

Indices: The FTSE 100 awakens

Indices: The FTSE 100 awakens

April 16, 2024 at 05:22 am EDT

Rankings

Highest BEL-20 increases
ELIA GROUP NV/SA	+1.09%
KBC GROUPE NV	+0.82%
AGEAS SA/NV	+0.37%
GROUPE BRUXELLES LAMBERT SA	+0.51%
COFINIMMO	+0.48%

The sharpest declines in BEL-20.
UMICORE	-0.38%
SOFINA SA	-0.66%
GALAPAGOS NV	-0.95%
ARGENX SE	-1.38%
MELEXIS N.V.	-1.58%

See the ranking

% Price Change by Sector

ETF components Amundi BEL 20 UCITS ETF - Dist - EUR

Color :

Weighting Schemes :

Grouping :

Detailed heatmap

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer